Although p53, Notch, and Hippo pathways have provided a basis for the development of various liver cancer drugs [32,33], liver cancer drugs (sorafenib) targeting these pathways often show significant side effects, including hand–foot syndrome, hypertension, diarrhea, and fatigue [34]. The gene discussed is TP53; the disease is liver cancer.